APVO

Aptevo Therapeutics Inc

• TipRanks·2d ago

  Aptevo Shareholders Back Board, Auditor and Incentive Plan

• TipRanks·2d ago

  Aptevo Therapeutics files to sell 6.44M shares of common stock for holders

• TipRanks·5d ago

  Analysts Offer Insights on Healthcare Companies: Aptevo Therapeutics (APVO) and Jasper Therapeutics (JSPR)

• TipRanks·08/16 13:30

  Aptevo Therapeutics reports $9.8M in cash, cash equivalents as of June 30

• Benzinga·08/14 12:32

  Aptevo Therapeutics Q2 EPS $(5.31) Beats $(6.16) Estimate

• TipRanks·08/13 21:20

  Aptevo Therapeutics Raises Capital Through Warrant-Induced Financing

• Benzinga·08/13 20:19

  Aptevo Therapeutics Closes Warrant Inducement Transaction, Issuing New Warrants For 1.27M Shares At $4.03 Per Share; Sells 861,708 Shares In $4.03 PIPE

• TipRanks·07/27 20:37

  Aptevo Therapeutics Unveils New Solid Tumor Strategy

• Benzinga·07/27 20:24

  Reported Earlier: Aptevo Therapeutics Announces A New Solid Strategy Designed To Fight Cancer On Multiple Fronts; Files A Patent Application Covering A Proprietary Nectin-4 X PD-L1 Dual-Targeting Backbone Designed To Strengthen Aptevo's Oncology Pipeline

• TipRanks·07/27 12:20

  Aptevo files patent application for Nectin-4 x PD-L1 dual-targeting backbone

• Benzinga·07/09 12:05

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• Benzinga·07/09 08:53

  Why Ultra Clean Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

• Benzinga·07/08 21:05

  12 Health Care Stocks Moving In Wednesday's After-Market Session

• Benzinga·07/08 20:00

  Aptevo Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS, ANTIBODIES AGAINST 4-1BB, ANTIBODIES AGAINST OX40 (FOR THE TREATMENT OF CANCER)".

• TipRanks·06/30 20:35

  Aptevo Therapeutics Secures Grant for APVO451 Development